Warren D. Cooper, Director at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 40 shares at $1.01 ($40) on 2022-06-14, disclosed to the SEC on 2022-06-16.
Open-market sale of $40 ZYNE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NXXI | BUY | 2007-10-16 | $8K | — | Filing → |